Evaluation of tolerability and anti-tumor activity of GDC-0980, an oral PI3K/mTOR inhibitor, administered to patients with advanced malignant pleural mesothelioma (MPM) Meeting Abstract
| Authors: | Dolly, S. O.; Krug, L. M.; Wagner, A. J.; Schwartz, L. H.; Bendell, J. C.; Lauchle, J. O.; Seiwert, T. Y.; Rihawi, K.; Tunariu, N.; Zauderer, M. G.; Delasos, L.; Kwiatkowski, D.; Marcoux, J. P.; Rabin, M. S.; Apt, D.; Fredrickson, J.; Lackner, M.; Koeppen, H.; Ware, J. A.; Burris, H. A.; de Bono, J. S.; Kindler, H. |
| Abstract Title: | Evaluation of tolerability and anti-tumor activity of GDC-0980, an oral PI3K/mTOR inhibitor, administered to patients with advanced malignant pleural mesothelioma (MPM) |
| Meeting Title: | 15th World Conference on Lung Cancer (IASLC) |
| Keywords: | pi3k; mtor; gdc-0980; mpm |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 8 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2013 Oct 27-31 |
| Meeting Location: | Sydney, Australia |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2013-11-01 |
| Start Page: | S307 |
| End Page: | S308 |
| Language: | English |
| ACCESSION: | WOS:000339624901155 |
| PROVIDER: | wos |
| DOI: | 10.1097/01.JTO.0000438438.14562.c8 |
| Notes: | Meeting Abstract: MO09.01 -- Source: Wos |
Altmetric
Citation Impact
